These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1567483)

  • 21. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of ribonucleotide reductase by antitumor agents related to levodopa and dopamine.
    FitzGerald GB; Wick MM
    Biochem Pharmacol; 1985 Feb; 34(3):353-60. PubMed ID: 3882092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribonucleotide reductase as a chemotherapeutic target.
    Cory JG
    Adv Enzyme Regul; 1988; 27():437-55. PubMed ID: 3074632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
    Egorin MJ; Fox BM; Spiegel JF; Gutierrez PL; Friedman RD; Bachur NR
    Cancer Res; 1985 Mar; 45(3):992-9. PubMed ID: 3971389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New inhibitors of the thioredoxin-thioredoxin reductase system based on a naphthoquinone spiroketal natural product lead.
    Wipf P; Hopkins TD; Jung JK; Rodriguez S; Birmingham A; Southwick EC; Lazo JS; Powis G
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2637-41. PubMed ID: 11551767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thioredoxin reductase as a novel molecular target for cancer therapy.
    Nguyen P; Awwad RT; Smart DD; Spitz DR; Gius D
    Cancer Lett; 2006 May; 236(2):164-74. PubMed ID: 15955621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of diaziquone free radicals on the in vitro activity of diaziquone.
    Nguyen B; Biswal S; Gutierrez PL
    Xenobiotica; 1988 May; 18(5):593-602. PubMed ID: 2840783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
    Findenig G; Vielnascher E; Göbl R; Fritzer-Szekeres M; Szekeres T
    Wien Klin Wochenschr; 1995; 107(22):694-7. PubMed ID: 8533431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.
    Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE
    Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
    Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
    Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines.
    Zhao F; Yan J; Deng S; Lan L; He F; Kuang B; Zeng H
    Cancer Lett; 2006 May; 236(1):46-53. PubMed ID: 15982805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.
    Powis G; Wipf P; Lynch SM; Birmingham A; Kirkpatrick DL
    Mol Cancer Ther; 2006 Mar; 5(3):630-6. PubMed ID: 16546977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and ribonucleotide reductase inhibitory activity of analogues of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY).
    Goddard AJ; Orr RM; Stock JA; Wilman DE
    Anticancer Drug Des; 1987 Dec; 2(3):235-45. PubMed ID: 3329526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular thioredoxin reductase activity is regulated by selenium.
    Berggren M; Gallegos A; Gasdaska J; Powis G
    Anticancer Res; 1997; 17(5A):3377-80. PubMed ID: 9413175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone.
    Ngo EO; Nutter LM; Sura T; Gutierrez PL
    Chem Res Toxicol; 1998 Apr; 11(4):360-8. PubMed ID: 9548807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of thioredoxin reductase by lanthanum chloride.
    Citta A; Folda A; Scutari G; Cesaro L; Bindoli A; Rigobello MP
    J Inorg Biochem; 2012 Dec; 117():18-24. PubMed ID: 23078771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.
    Cory JG; Downes DL; Cory AH; Schaper KJ; Seydel JK
    Anticancer Res; 1994; 14(3A):875-9. PubMed ID: 8074487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells.
    Liu JJ; Liu Q; Wei HL; Yi J; Zhao HS; Gao LP
    Pharmazie; 2011 Jun; 66(6):440-4. PubMed ID: 21699084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.